Filtration Fraction Cvvh Calculator

Estimate filtration fraction in CVVH to reduce hemoconcentration, preserve filter life, and optimize bedside CRRT settings.

Clinical convention often targets FF below 20% to 25%, adjusted for anticoagulation strategy and institutional protocol.

Complete Expert Guide to the Filtration Fraction CVVH Calculator

A filtration fraction CVVH calculator is one of the most practical tools for bedside continuous kidney replacement therapy management. In continuous venovenous hemofiltration, you are constantly balancing clearance goals, hemodynamic stability, anticoagulation performance, and circuit longevity. Filtration fraction sits at the center of that balance because it reflects how aggressively plasma water is being removed across the hemofilter relative to incoming plasma water flow.

At a clinical level, filtration fraction helps answer a simple but high impact question: Is this circuit likely to hemoconcentrate and clot prematurely? High filtration fractions increase blood viscosity in the filter, increase transmembrane stress, and can shorten filter life, especially when anticoagulation is not optimal. A thoughtful filtration fraction target can improve treatment continuity, reduce nursing burden from recurrent circuit loss, and lower blood product exposure when repeated clotting causes blood loss in the circuit.

The calculator above is designed for fast bedside use with common input variables: blood flow, hematocrit, pre-filter replacement, and effluent flow. It also offers a plasma water correction factor and a configurable target threshold so teams can match institutional protocol. While no single formula captures every machine setup or brand-specific algorithm, this approach gives a reliable and transparent estimate for everyday CRRT decisions.

What Is Filtration Fraction in CVVH?

In CVVH, filtration fraction (FF) is the proportion of plasma water that is ultrafiltered as blood passes through the filter. A common practical expression is:

FF (%) = 100 x (Effluent or ultrafiltration rate) / (Plasma water flow into filter)

Plasma water flow is often estimated from blood flow and hematocrit, and in pre-dilution setups many clinicians add pre-filter replacement flow to the denominator to account for dilution before the membrane:

• Post-dilution estimate: denominator approximately Qb x (1 – Hct)
• Pre-dilution corrected estimate: denominator approximately Qb x (1 – Hct) + pre-filter replacement flow
• Optional protein correction: multiply plasma component by 0.93 when using plasma water correction

Most centers use operational targets around less than 20% to 25%, with some tolerance above that in specific scenarios. Practical thresholds vary by anticoagulation approach, catheter quality, blood flow reliability, and filter brand.

How to Use This Calculator Step by Step

1. Choose the calculation mode. Use post-dilution estimate for classic bedside approximations, or pre-dilution corrected mode if your replacement is delivered before the filter.
2. Enter blood flow in mL/min. Confirm the value is true delivered flow, not only prescribed flow.
3. Enter current hematocrit as a percentage from the most relevant lab.
4. Enter pre-filter replacement rate in mL/hr. If none, use zero.
5. Enter effluent rate in mL/hr. In CVVH this generally represents convective ultrafiltrate flow plus net fluid removal according to your setup.
6. Select plasma water correction factor (1.00 simplified, 0.93 protein-corrected).
7. Optionally enter weight to display effluent dose in mL/kg/hr.
8. Set your institutional target max FF and click Calculate.

The result panel returns filtration fraction, estimated plasma water inflow, target-aligned guidance, and a suggested blood flow needed to achieve your selected maximum filtration fraction if current settings are high.

How to Interpret the Result

• Below 20%: commonly favorable for circuit patency in many units, especially when anticoagulation is modest.
• 20% to 25%: often acceptable, but monitor pressure trends and filter performance carefully.
• Above 25%: rising risk of hemoconcentration and premature filter clotting, especially with low blood flow, access recirculation, or suboptimal anticoagulation.

Interpretation should never be isolated from machine pressure data. If transmembrane pressure and filter pressure rise together, and the filtration fraction is high, lowering FF is a high value intervention. Typical options include increasing blood flow, shifting replacement toward pre-filter when appropriate, reducing effluent temporarily, optimizing vascular access, or reassessing anticoagulation strategy.

Evidence Snapshot: CRRT Dose and Outcomes

Filtration fraction is not the same as effluent dose, but both variables are linked operationally because higher prescribed effluent can push FF upward if blood flow and dilution are unchanged. Large randomized trials help frame realistic dosing expectations and support avoiding unnecessary over-intensification.

Trial	Population and size	Intervention comparison	Main mortality outcome	Clinical message for CVVH settings
ATN Trial (NEJM 2008)	Critically ill adults with AKI, n = 1124	Intensive strategy vs less-intensive strategy	60-day mortality 53.6% vs 51.5%	No mortality benefit from higher intensity; avoid pushing effluent without clear indication.
RENAL Study (NEJM 2009)	ICU patients on CRRT, n = 1508	40 vs 25 mL/kg/hr effluent	90-day mortality 44.7% vs 44.5%	Higher dose did not improve survival; preserving circuit function and delivery consistency is crucial.
STARRT-AKI (NEJM 2020)	Severe AKI in ICU, n = 3019	Accelerated vs standard initiation strategy	90-day mortality 43.9% vs 43.7%	Timing and intensity decisions should be individualized; quality of delivered therapy remains central.

These data reinforce a core principle: better outcomes come from reliable delivered therapy, fewer interruptions, and thoughtful personalization, not just larger numbers on prescribed clearance. Filtration fraction control supports that reliability by helping maintain filter longevity and reducing downtime.

Operational Benchmarks for Filtration Fraction Management

Operational parameter	Common benchmark	Why it matters	Typical adjustment when outside target
Filtration fraction	Often targeted below 20% to 25%	Lower hemoconcentration and lower clot risk in many circuits	Increase Qb, increase pre-dilution, reduce effluent, optimize access
Delivered CRRT dose	Often prescribed 25 to 30 mL/kg/hr to deliver 20 to 25 mL/kg/hr	Accounts for interruptions and downtime	Track delivered dose daily and troubleshoot causes of treatment loss
Circuit life	Many ICUs aim for 24+ hours, frequently longer with citrate protocols	Longer filter life improves continuity and nursing efficiency	Reassess FF, anticoagulation, and catheter performance

These are practical benchmarks, not rigid rules. A hypotensive patient with limited blood flow and urgent metabolic control may require compromises. The goal is informed tradeoff, not blind target chasing.

Common Errors That Cause Misleading Filtration Fraction Estimates

• Using prescribed blood flow instead of true delivered blood flow when access dysfunction is present.
• Mixing units, especially mL/min and mL/hr, without conversion.
• Ignoring pre-filter replacement in pre-dilution setups.
• Confusing total effluent with net fluid removal alone.
• Using outdated hematocrit in rapidly changing ICU patients.
• Interpreting a single value without pressure trends and clinical context.

A high quality workflow pairs calculator output with machine pressures, recent lab trends, and bedside assessment of line function. If the numeric FF looks acceptable but filter life remains short, focus on catheter position, access recirculation, anticoagulation protocol adherence, and repeated blood flow interruptions.

Practical Bedside Strategy to Lower High Filtration Fraction

1. Confirm data quality first: true blood flow, actual effluent, current hematocrit.
2. Increase blood flow if access permits and hemodynamics tolerate.
3. Increase pre-filter replacement fraction when using pre-dilution protocols.
4. Temporarily reduce effluent if clotting is recurrent and metabolic indications allow.
5. Reassess anticoagulation pathway and target attainment, including citrate workflow where used.
6. Evaluate vascular access function and consider catheter repositioning or exchange when persistent alarms occur.

This stepwise approach often improves filter life faster than repeated unstructured adjustments. It also helps maintain delivered dose over 24 hours by reducing circuit interruptions.

Authoritative Reading and Data Sources

• ATN Study (NEJM, PubMed, .gov)
• RENAL Study (NEJM, PubMed, .gov)
• NIDDK Acute Kidney Injury Overview (.gov)

For protocol implementation, always align calculator use with local ICU nephrology guidance, nursing workflows, and machine-specific operating procedures.

Final Takeaway

A robust filtration fraction CVVH calculator does more than produce a percentage. It creates a structured decision point that links blood flow, dilution strategy, effluent prescription, and circuit durability. In everyday ICU practice, that structure can reduce avoidable clotting, improve delivered therapy, and support safer, more consistent renal support for critically ill patients. Use the value dynamically, recheck after each major setting change, and interpret results together with pressures, labs, and patient trajectory.